Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus.
Playford
David A
DA
University Department of Medicine, the University of Western Australia, Royal Perth Hospital, Perth, Australia.
Watts
Gerald F
GF
Best
James D
JD
Burke
Valerie
V
D001916:Brachial Artery / Q000187:drug effects / Q000502:physiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004311:Double-Blind Method; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D005260:Female; D011345:Fenofibrate / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012039:Regional Blood Flow / Q000187:drug effects; D012307:Risk Factors; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects*
D000960:Hypolipidemic Agents; D011345:Fenofibrate